Skip to content
Research Article Open access CC BY 4.0

Comparison of Blood and Urine Profiles of Remogliflozin in Rat PK Study Using a Single and Simple UPLC Method

G. K. Aiswarya, P. C. Indukala, S. Kathirvel, K. Raja Rajeswari

Asian Journal of Research in Nephrology · pp. 53–63 · Published 13 May 2023

Abstract

This study describes a comparison between blood and urine profiles of Remogliflozin simultaneously in a rat pharmacokinetic study using a simple UPLC method. Quantitative determination of Remogliflozin is performed in rat blood with the recovery values in the range of 85-115%. A reversed phase Ultra-performance liquid chromatography (UPLC) with UV detector is used. The method utilizes an Acquity UPLC CSH Fluoro-Phenyl column (150x1mm, 1.7 µm) and a gradient elution with mobile phase consisting of acetonitrile and 0.1% formic acid (15:85) at a flow rate of 0.8 mL min-1. The method adequately resolves the analyte and internal standard (metformin) within a run time of 5 min. The UV detection carried out at 275 nm. In both blood and urine, the detection limit of Remogliflozin is found to be 2 µg mL-1 and the LOQ as 10 µg mL-1. Two profiles were compared by conducting single oral dose in vivo rat PK study after complete validation of the UPLC method.

Antidiabetic remogliflozin pharmacokinetics UPLC rat blood and Urine

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.